News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
164,965 Results
Type
Article (6333)
Company Profile (111)
Press Release (158516)
Multimedia
Podcasts (5)
Webinars (7)
Section
Business (49822)
Career Advice (234)
Deals (7413)
Drug Delivery (24)
Drug Development (20681)
Employer Resources (22)
FDA (2087)
Job Trends (4967)
News (80160)
Policy (4892)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (490)
Accelerated approval (8)
Adcomms (3)
Allergies (36)
Alliances (13377)
ALS (57)
Alzheimer's disease (481)
Antibody-drug conjugate (ADC) (106)
Approvals (2177)
Artificial intelligence (132)
Autoimmune disease (64)
Automation (14)
Bankruptcy (61)
Best Places to Work (4286)
BIOSECURE Act (14)
Biosimilars (29)
Biotechnology (97)
Bladder cancer (56)
Brain cancer (15)
Breast cancer (281)
Cancer (1688)
Cardiovascular disease (65)
Career advice (221)
Career pathing (5)
CAR-T (133)
CDC (3)
Celiac Disease (1)
Cell therapy (347)
Cervical cancer (10)
Clinical research (18246)
Collaboration (628)
Compensation (296)
Complete response letters (6)
COVID-19 (549)
CRISPR (25)
C-suite (390)
Cystic fibrosis (47)
Data (2253)
Depression (24)
Diabetes (143)
Diagnostics (1235)
Digital health (3)
Diversity, equity & inclusion (8)
Drug discovery (100)
Drug pricing (26)
Drug shortages (6)
Duchenne muscular dystrophy (54)
Earnings (16132)
Editorial (8)
Employer branding (1)
Employer resources (21)
Events (31135)
Executive appointments (416)
FDA (2879)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (14)
Funding (533)
Gene editing (54)
Generative AI (12)
Gene therapy (209)
GLP-1 (201)
Government (533)
Guidances (89)
Healthcare (2788)
HIV (9)
Huntington's disease (12)
IgA nephropathy (43)
Immunology and inflammation (70)
Immuno-oncology (15)
Indications (27)
Infectious disease (617)
Inflammatory bowel disease (77)
Inflation Reduction Act (3)
Influenza (38)
Intellectual property (86)
Interviews (19)
IPO (3493)
IRA (12)
Job creations (807)
Job search strategy (202)
JPM (3)
Kidney cancer (3)
Labor market (17)
Layoffs (63)
Leadership (2)
Legal (1193)
Liver cancer (20)
Longevity (2)
Lung cancer (165)
Lymphoma (161)
Machine learning (16)
Management (4)
Manufacturing (281)
MASH (20)
Medical device (1337)
Medtech (1340)
Mergers & acquisitions (4286)
Metabolic disorders (284)
Multiple sclerosis (59)
NASH (1)
Neurodegenerative disease (84)
Neuropsychiatric disorders (19)
Neuroscience (842)
Neurotech (1)
NextGen: Class of 2026 (1217)
Non-profit (656)
Now hiring (11)
Obesity (115)
Opinion (46)
Ovarian cancer (75)
Pain (58)
Pancreatic cancer (83)
Parkinson's disease (109)
Partnered (9)
Patents (143)
Patient recruitment (190)
Peanut (17)
People (19815)
Pharmaceutical (12)
Phase 1 (7036)
Phase 2 (8621)
Phase 3 (4641)
Pipeline (1657)
Policy (51)
Postmarket research (322)
Preclinical (3000)
Press Release (51)
Prostate cancer (54)
Psychedelics (5)
Radiopharmaceuticals (64)
Rare diseases (199)
Real estate (1758)
Recruiting (13)
Regulatory (4097)
Reports (16)
Research institute (523)
Resumes & cover letters (24)
Rett syndrome (19)
RNA editing (4)
RSV (14)
Schizophrenia (21)
Series A (95)
Series B (80)
Service/supplier (3)
Sickle cell disease (26)
Special edition (3)
Spinal muscular atrophy (41)
Sponsored (6)
Startups (1111)
State (1)
Stomach cancer (2)
Supply chain (26)
Tariffs (16)
The Weekly (5)
Vaccines (161)
Venture capital (21)
Weight loss (55)
Women's health (12)
Worklife (2)
Date
Today (32)
Last 7 days (178)
Last 30 days (628)
Last 365 days (9565)
2026 (1022)
2025 (9590)
2024 (10502)
2023 (11384)
2022 (13869)
2021 (14800)
2020 (12252)
2019 (9429)
2018 (7249)
2017 (7378)
2016 (6856)
2015 (7913)
2014 (6051)
2013 (4865)
2012 (5386)
2011 (5909)
2010 (5394)
Location
Africa (163)
Alabama (54)
Alaska (1)
Arizona (48)
Arkansas (4)
Asia (9557)
Australia (2196)
California (3892)
Canada (995)
China (287)
Colorado (92)
Connecticut (140)
Delaware (62)
Europe (20992)
Florida (420)
Georgia (62)
Hawaii (2)
Idaho (15)
Illinois (219)
India (18)
Indiana (205)
Iowa (4)
Japan (113)
Kansas (16)
Kentucky (4)
Louisiana (3)
Maine (5)
Maryland (393)
Massachusetts (2896)
Michigan (107)
Minnesota (172)
Mississippi (1)
Missouri (17)
Montana (11)
Nebraska (3)
Nevada (27)
New Hampshire (7)
New Jersey (763)
New Mexico (8)
New York (907)
North Carolina (514)
North Dakota (5)
Northern California (1889)
Ohio (76)
Oklahoma (8)
Oregon (8)
Pennsylvania (664)
Puerto Rico (9)
Rhode Island (8)
South America (224)
South Carolina (5)
Southern California (1556)
Tennessee (29)
Texas (1381)
United States (13220)
Utah (46)
Virginia (36)
Washington D.C. (10)
Washington State (516)
West Virginia (1)
Wisconsin (26)
164,965 Results for "fujifilm diosynth biotechnologies texas".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FUJIFILM Biotechnologies Welcomes Samuel Hernandez as Site Head of Texas Facility
September 5, 2025
·
3 min read
Press Releases
FUJIFILM Diosynth Biotechnologies and Regeneron Sign a 10-Year U.S. Manufacturing Agreement Valued at Over $3 Billion
April 22, 2025
·
5 min read
Bio NC
Jacobs Selected to Support Delivery of $1.2B Expansion of FUJIFILM Diosynth Biotechnologies’ Large-Scale Biologics Manufacturing Site
Jacobs was selected by FUJIFILM Diosynth Biotechnologies to support delivery of $1.2 billion expansion of an end-to-end, large-scale cell culture contract manufacturing site in Holly Springs, North Carolina.
June 27, 2024
·
4 min read
Press Releases
FUJIFILM Irvine Scientific Now Officially FUJIFILM Biosciences
January 6, 2026
·
1 min read
Press Releases
FUJIFILM Biotechnologies Expands Strategic Partnership with argenx to Include U.S. Manufacturing Operations
September 19, 2025
·
4 min read
Press Releases
FUJIFILM Biotechnologies Celebrates the Grand Opening of its Commercial-Scale Cell Culture Manufacturing Site in North Carolina
September 25, 2025
·
6 min read
Press Releases
Fujifilm to Highlight Cutting-Edge Imaging Innovations at RSNA 2025
November 26, 2025
·
4 min read
Press Releases
Advanced Sterilization Products (ASP) Announces CE Mark for ULTRA GI™ Cycle for Duodenoscopes in Partnership with FUJIFILM Healthcare Europe
January 16, 2026
·
2 min read
Deals
FUJIFILM Diosynth Biotechnologies: There’s a New Cell Therapy Employer in Thousand Oaks
FUJIFILM Diosynth Biotechnologies is offering unique opportunities to join one of the top global CDMOs focused on solving some of the most complex healthcare challenges.
December 2, 2022
·
5 min read
·
Heather McKenzie
Bio NC
FUJIFILM Diosynth Biotechnologies Enters Into an Agreement with Argenx to Manufacture Efgartigimod, a monoclonal antibody (mAb) for the Treatment of Severe Autoimmune Diseases
FUJIFILM Diosynth Biotechnologies announced an agreement with argenx to manufacture efgartigimod, a monoclonal antibody fragment to target the neonatal Fc receptor, in patients with severe autoimmune disease.
October 27, 2022
·
3 min read
1 of 16,497
Next
